Photo taken from newatlas.com
Jul 6, 2024, 10:23
Pierre Blanchard: Silke Gillessen and Bertrand Tombal, on intermittent ADT/ARPI in metastatic prostrate cancer
Pierre Blanchard, Radiation Oncology Clinical section chief at Gustave Roussy Cancer Institute, shared on X:
“Excellent discussion by Silke Gillessen, Bertrand Tombal, on intermittent ADT/ARPI in hormone naïve metastatic prostrate cancer at GETUG research days.
New trials needed, especially for patients with deep PSA response (<0,2 ng/ml) after dual ADT/ARPI.”
Source: Pierre Blanchard/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19